Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyAbout this site
Pathology · Peking University Cancer Hospital · Beijing

Dr. Lin Dongmei林冬梅

Chief Physician · Professor

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

Dr. Lin Dongmei

Professional overview

Dr. Lin Dongmei is a Chief Physician and Professor in the Department of Pathology at Peking University Cancer Hospital, specializing in pathological diagnosis of thoracic tumors.

SpecialtyPathology
Clinical titleChief Physician
Academic rolesProfessor, Doctoral Supervisor
DepartmentDepartment of Pathology
HospitalPeking University Cancer Hospital
CityBeijing
Hospital roleDirector of the Department of Pathology, Director of the Pathology Teaching and Research Office

Areas of focus

Thoracic tumorsIncluding lung cancer, thymoma, esophageal cancer, and mesothelioma

Background

  • 1986Graduated from Shandong University School of Medicine (formerly Shandong Medical University) with an M.B. degree; began working at the Department of Pathology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
  • 2008Visiting scholar at the Center of Medical Oncology, Cancer Institute, Barts and The London, Queen Mary’s School of Medicine and Dentistry, University of London
  • 2014Joined the Department of Pathology, Peking University Cancer Hospital, as Director and Director of the Pathology Teaching and Research Office

Experience & recognition

  • Received doctoral degree from Peking Union Medical College
  • Appointed Doctoral Supervisor by Peking Union Medical College Graduate School in 2010
  • Authored or co-authored over 60 SCI papers
  • Principal investigator of five projects funded by the National Natural Science Foundation of China and Beijing municipal agencies

Professional roles

  • Member, Chinese Medical Association (CMA)
  • Member, International Association for the Study of Lung Cancer (IASLC)
  • Member, Expert Committee for the Guidelines on Diagnosis and Treatment of EGFR-Mutated and ALK-Fusion Gene-Positive Non-Small Cell Lung Cancer in China
  • Member, Expert Group for the Consensus on Diagnosis of ALK-Positive Non-Small Cell Lung Cancer in China, Chinese Society of Clinical Oncology (CSCO) Biomarker Committee
  • Academic Secretary, Thoracic Diseases Working Group, Pathology Branch, Chinese Medical Association (CMA)
  • Member, Pathology Professional Committee, China Anti-Cancer Association (CACA)
  • Standing Committee Member, Precision Medicine and Tumor MDT Professional Committee, Chinese Research Hospital Association
  • Deputy Chair, Tumor Immunology Professional Committee, Beijing Breast Disease Prevention and Treatment Society

Frequently asked questions

What does Dr. Lin Dongmei specialize in?

Specializes in pathological diagnosis of thoracic tumors, including lung cancer, thymoma, esophageal cancer, and mesothelioma

Which hospital and department is Dr. Lin Dongmei in?

Department of Pathology at Peking University Cancer Hospital

Sources

Dr. Lin Dongmei has not reviewed this page.